Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

君芬 - NMPA Drug Approval Details

Approvals/NMPA/Ganciclovir Injection

Approved

化学药品

Ganciclovir Injection

辰欣药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Feb 8, 2020
Approval ID: 7LeaeAaC2DQ
Company: 辰欣药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeAaC2DQ
Approval Number: 国药准字H20051041
Generic Name: 更昔洛韦注射液
Generic Name En: Ganciclovir Injection
Trade Name: 君芬
Brand Name: 君芬
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 1ml:50mg
Reg Date: 2020-02-08
Company Name: 辰欣药业股份有限公司
Production Company Name: 辰欣药业股份有限公司
Production Company Address: 济宁高新区海川路
Company Detail Path: /organization/cisen-pharmaceutical-co-ltd
Production Company Detail Path: /organization/cisen-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 8, 2020

Approval ID

7LeaeAaC2DQ

Type

化学药品

Back to NMPA Approvals